Co-occurrence of hereditary Tyrosinemia type 1 and refractory immune thrombocytopenia: a case report
Oxford Medical Case Reports · 2026-11-02 · 2026 (11)
DOI: 10.1093/omcr/omag205 ↗Abstract
Abstract Hereditary tyrosinemia type 1 (HT-1) is a rare metabolic disorder caused by fumarylacetoacetate hydrolase deficiency. We report a unique case of HT-1 co-occurring with refractory immune thrombocytopenia (ITP) in a 3.5-year-old female. The patient initially presented at five months with severe thrombocytopenia and coagulopathy. While nitisinone therapy successfully normalized liver function and coagulation parameters, severe thrombocytopenia persisted (<10 × 109/L) despite corticosteroids, IVIG, rituximab, and thrombopoietin receptor agonists. Bone marrow examination showed normal megakaryocytes, and secondary causes were excluded. This distinct dissociation between metabolic control and hematologic refractoriness suggests a complex interplay between metabolic dysregulation and autoimmunity. This is the first reported case of such co-occurrence, highlighting the importance of considering autoimmune complications in metabolic disorders.
EUVIMED